Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.50 |
| ▸ | MAPT | P10636 | 8/20 | 0.50 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | ATR | Q13535 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6337266 | 0.89 | DGAT1 (0.51) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| Trifluoroacetic Acid SCHEMBL6326606 | 0.87 | DGAT1 (0.51) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL6326588 | 0.85 | DGAT1 (0.49) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL6325802 | 0.83 | LMNA (0.46) | ALDH1A1MAPTRAB9ANPC1L3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL6333105 | 0.82 | DGAT1 (0.51) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| Trifluoroacetic Acid SCHEMBL6327439 | 0.82 | NPC1 (0.46) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| Trifluoroacetic Acid SCHEMBL6328364 | 0.81 | DGAT1 (0.44) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL5726776 | 0.81 | DGAT1 (0.47) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL6326610 | 0.80 | DGAT1 (0.47) | DGAT1ALDH1A1MAPTRAB9ANPC1 | |
| SCHEMBL6329116 | 0.80 | MAPT (0.51) | ALDH1A1MAPTRAB9AL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | BAYER PHARMACEUTICALS CORPORATION | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | GPR119, EGLN3, PC | DGAT1 386/4885ALDH1A1 991/4885MAPT 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.